Development of a Clinical Guideline for Suicide Prevention in Psychiatric Patients Based on the ADAPTE Methodology
- Author:
Jeong Hun YANG
1
;
Jieun YOO
;
Dae Hun KANG
;
C. Hyung Keun PARK
;
Sang Jin RHEE
;
Min Ji KIM
;
Sang Yeol LEE
;
Se-Hoon SHIM
;
Jung-Joon MOON
;
Seong-Jin CHO
;
Shin Gyeom KIM
;
Min-Hyuk KIM
;
Jinhee LEE
;
Won Sub KANG
;
Weon-Young LEE
;
Yong Min AHN
Author Information
- Publication Type:Original Article
- From:Psychiatry Investigation 2024;21(10):1149-1166
- CountryRepublic of Korea
- Language:English
-
Abstract:
Objective:Suicide is a significant public health issue, with South Korea having the highest suicide rate among Organisation for Economic Cooperation and Development countries. This study aimed to develop clinical guidelines for suicide prevention in psychiatric patients in Korea using the ADAPTE methodology.
Methods:The development process involved a comprehensive review of literature, expert consultations, and consensus-building using the Nominal Group Technique and Delphi method. The guidelines focus on evidence-based psychiatric treatments, including both pharmacological and non-pharmacological approaches, tailored to the Korean context. Key findings underscoring the need for standardized treatment protocols for patients with major psychiatric disorders, including bipolar disorder, major depressive disorder, and schizophrenia.
Results:The guidelines incorporate treatments like lithium, clozapine, atypical antipsychotics, electroconvulsive therapy, and cognitive behavioral therapy, which have shown effectiveness in suicide prevention. Applicability and acceptability within Korea’s healthcare system were addressed, ensuring feasibility given the country’s medical insurance coverage and accessibility. The guidelines were validated through expert reviews and Delphi rounds, achieving consensus on the final recommendations.
Conclusion:The developed guidelines provide a structured, evidence-based approach to reducing suicide rates among psychiatric patients in Korea. Future research will focus on expanding these guidelines to include screening protocols for high-risk groups.
